AKASA vs Charta Health (2026)
Two provider side coding platforms separated by timing and scope. AKASA runs one engine across coding, documentation integrity and the surrounding claim work, which suits a health system standardising the whole function on a single vendor. Charta reviews every encounter before the bill goes out, coding each visit from the provider's own documentation so problems surface while they are still cheap to fix. For a practice whose pain is denials, pre bill is the right moment and Charta is built for it. For an enterprise revenue cycle programme, AKASA covers more of the estate and reduces the handoffs where errors accumulate. Neither publishes the number that separates accuracy from optimisation, which is how many codes their review takes off against how many it adds.
- One engine spans coding, clinical documentation integrity and the claim work around them, so a health system standardises on a single revenue cycle vendor rather than assembling one.
- The commercial track record is longer, which for a function that touches every encounter is worth more than a feature advantage.
- For an enterprise programme, breadth across the function reduces the number of handoffs where errors and finger pointing accumulate.
- Pre bill review runs across every encounter rather than a retrospective sample, so the error is caught before the claim leaves rather than after a denial arrives.
- Coding comes from the provider's own documentation, tying the output to what was actually written rather than to what a reviewer inferred later.
- For a practice whose problem is denials rather than throughput, the pre bill moment is the cheapest possible place to intervene.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Charta Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AKASA | Charta Health |
|---|---|---|
| Primary category | RCM & Prior Auth AI | Autonomous Medical Coding |
| Founded | Not recorded | 2023 |
| Headquarters | South San Francisco, California | San Francisco, California, United States |
| Website | akasa.com | chartahealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards AKASA its top capability grade on AI Centrality, Security Certifications and Trust Center and Setting and Specialty Coverage. Set against Charta Health, AKASA grades higher on Security Certifications and Trust Center, AI Governance and Bias Disclosure and Setting and Specialty Coverage. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Charta Health its top capability grade on AI Centrality and Autonomy and Oversight Model. Set against AKASA, Charta Health grades higher on Autonomy and Oversight Model and FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose AKASA or Charta Health?
On the axes where the AI Health Index separates them, AKASA grades higher on Security Certifications and Trust Center, AI Governance and Bias Disclosure and Setting and Specialty Coverage, and Charta Health grades higher on Autonomy and Oversight Model and FDA and Regulatory Status. AKASA leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do AKASA and Charta Health differ most?
The widest separation the AI Health Index records between AKASA and Charta Health is on Security Certifications and Trust Center, where AKASA grades A and Charta Health grades B. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do AKASA and Charta Health grade the same?
The AI Health Index grades AKASA and Charta Health the same on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Both vendors sit on the coding gradient and neither publishes what would settle it: the ratio of codes removed to codes added, and what proportion of suggestions survive a payer audit. A review that raises the coding level and a review that raises audit exposure look identical on every metric either reports. Neither publishes an accuracy figure, a model description or an evaluation methodology, and neither publishes pricing. Ask both what happens contractually when a payer disputes documentation their software produced, because the practice signs the claim and carries the exposure.